Patients with a poor outcome expressed PDPN broadly across the tumor microenvironment whilst HIF-1α and VEGF expression also extended into the distal stromal and immune regions and likely indicates more extensive hypoxia in this subgroup. The gene discussed is HIF1A; the disease is neoplasm.